📰
Politics
Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO
📅8 April 2026 at 20:42
📰Bloomberg
👁️0 views
Share:
📰
Article Preview
Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering.
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.